Filing Flows › Selectis Health (GBCS) › Q1 2026
Selectis Health (GBCS) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 22, 2026
Selectis Health (GBCS) reported revenue of $7.3M for the first quarter 2026 (Q1 2026), -30% from a year earlier and -25% from the quarter before. Operating margin was -17.3%, net earnings $6.5M (89.5% of revenue).
Selectis Health, Q1 2026: revenue $7.3M (-30% year over year), operating margin -17.3%, net earnings $6.5M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.3M | -25% | -30% |
| Operating profit | −$1.3M | — | — |
| Net earnings | $6.5M | — | — |
| Operating cash flow | −$2.3M | -456% | -321% |
What changed
Revenue was $7.3M in Q1 2026, down 30% year over year and down 25% from the previous quarter. Health Care was the largest line at 99% of revenue. Health Care lost $3.3M year over year (down 32%), 103% of the total change.
Operating costs exceeded revenue by $1.3M, an operating margin of -17.3%. Total costs fell 22% while revenue fell 30%. Net earnings were $6.5M. The effective tax rate was 5.9%. Non-operating items added $8.2M, 118% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$2.3M. Non-cash charges added back $333K of depreciation. Working capital and other items used $9.1M. Capital expenditures of $377K exceeded it, leaving free cash flow of −$2.7M.
Questions
What was Selectis Health's revenue in the first quarter 2026?
Selectis Health (GBCS) reported revenue of $7.3M for the first quarter 2026 (Q1 2026), -30% from a year earlier and -25% from the quarter before.
Was Selectis Health profitable in the first quarter 2026?
Operating loss was $1.3M (-17.3% of revenue) and net earnings $6.5M.
Source: Selectis Health 10-Q on SEC EDGAR.